Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + cisplatin vs vinorelbine + cisplatin after complete resection of non-squamous NSCLC
jRCTs041180023Phase 3Completed
- Sponsor
- Ministry of Health, Labour and Welfare
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Non-small cell lung cancer (NS-NSCLC) comparing Vinorelbine + cisplatin with Pemetrexed + cisplatin (2 arms). Primary endpoint: Disease-free survival. Started Mar 2012; status: completed.
02
Drugs
pemetrexedcisplatinvinorelbine
03
Conditions
Non-small cell lung cancer (NS-NSCLC)
Beyond the preview
Go deeper on jRCTs041180023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180023.